clinical management of siravatham (cerebral palsy) by siddha medicine.

CLINICAL EVALUATION OF SIDDHA THERAPEUTIC MANAGEMENT FOR SIRAVADHAM (CEREBRAL PALSY) IN CHILDREN

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019928

Enrollment

Registered

2019-06-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G80- Cerebral palsy

Interventions

Intervention1: SAGALAVATHA CHOORANAM (Internal)and KUEUNTHOTTI THYLAM (External)VALUZHUVAI THYLAM (External): SAGALAVATHA CHOORANAM is multi herbal formulation. Dosage of this drug 250 mg to 750 mg du

Eligibility

Inclusion criteria

Inclusion criteria: Stiffness in muscles Difficult to sit,stand and walk Difficulty to swallowing and eating Developmental delay Lack of muscle coordination

Exclusion criteria

Exclusion criteria: Ataxic cerebral palsy. Dyskinetics cerebral palsy. mixed type of cerebral palsy. ADD/ADHD SEIZURE DISORDER Spina bifida down syndrome visual impairment

Design outcomes

Primary

Measure	Time frame
A clinical assessment and evaluation of siravatham (cerebral palsy) with siddha therapeutic management in childrenTimepoint: 1-90 days	—

Secondary

Measure	Time frame
Improvement in the quality of life in children. Improvement in clinical symptoms. Timepoint: 3 months	—

Countries

India

Contacts

Public ContactDrArulmozhi

National; Institute of Siddha

mmssiddha@gmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026